Navigation Links
Save The Cord Foundation, a Global Leader in Cord Blood Advocacy, Announces its Expansion of Educational Information Surrounding Other Non-Controversial Stem Cell Sources
Date:4/30/2013

Tucson, Arizona (PRWEB) April 30, 2013

Save the Cord Foundation, a trusted non commercial resource for education and awareness of umbilical cord blood and cord tissue preservation, today announced it will expand its web information base to include the new industry-changing technologies that allow for the collection and storage of Dental Pulp Stem Cells, a type of multi-potent adult stem cell found in the pulp chamber of teeth, that show a strong potential to treat a variety of diseases.

Save the Cord Foundation is a 501c3 nonprofit (tax-exempt) foundation created to advance cord blood and cord tissue awareness, education, research and legislation. The foundation’s mission is to provide FREE, unbiased, factual information to expectant parents and the public concerning the medical value and life-saving benefits of saving umbilical cord blood and the future potential for using cord tissue as a regenerative medical resource.

The foundation educates expectant parents about the medical value of their newborn’s cord blood, so they can make their own informed decision about the options for saving it; public donation, private banking or donation to research. Save the Cord Foundation’s vision is to make saving cord blood the standard of care for all newborns and cord blood preservation an accessible option for expectant parents at birthing hospitals across our nation and around the world.

A major advantage individuals get from harvesting stem cells from their dental pulp and own body is that there is no rejection of these cells when they are harvested and subsequently re-implanted. In the future, medical researchers anticipate being able to use technologies derived from stem cell research to treat a wider variety of diseases including Parkinson’s, Alzheimer’s, spinal cord injuries, diabetes, heart diseases, liver disease, multiple sclerosis, muscle damage and many other diseases. The discovery that human dental pulp tissue contains a population of multi-potent mesenchymal dental pulp stem cells with the ability to reproduce quickly for self-renewal and the ability to differentiate into functional odontoblast has revolutionized dental research and opened new avenues for reparative and reconstructive dentistry and tissue engineering.

“Dental pulp is a very valuable source of non-controversial mesenchymal stem cells that show great future potential in treating many disorders, given the fact that these mesenchymal cells can be extracted from teeth, opens up a new opportunity for every member of the family to preserve these valuable stem cells as a personal or family medical resource for future use”, said Charis Ober, Co-Founder of Save the Cord Foundation.

Dental pulp stem cells, found in the pulp chamber of teeth, are a relatively new discovery in the realm of adult stem cells; they have the ability to differentiate into numerous cell types including bone, muscle, nerve, cartilage and fat. Dental pulp stem cells hold the potential of possibly regenerating damaged tissues and organs in the body by stimulating organs to heal themselves. These cells may be one of the most promising cell-therapies in the future. In the past, extracted teeth and related tissue have been viewed as a medical waste and discarded, resulting in a loss of this potential life-saving resource. Now clients can save these cells so they are available to them in the future should they be necessary.

“Very much like cord blood, a child’s loose tooth, extracted wisdom or adult teeth and pulpectomy can provide first-rate stem cells that can potentially be used in cellular-therapy based applications down the road in the emerging field of regenerative or personalized medicine”, added Jose Cirino, Director of Operations at GeneCell International, who was interviewed on the topic of dental pulp stem cells.

The significance of these cells is that they can differentiate and give rise to many different tissue types, including bone (osteoblasts), fat (adipocytes), cartilage (chondrocytes), muscle (myocytes) and neural cells (including dopaminergic neurons). The fact that these cells can easily be extracted from teeth opens up a new gateway to raw material that can potentially be used in the emerging field of “regenerative or personalized medicine.”

Please visit http://www.savethecordfoundation.org regarding any questions and resources concerning the collection and preservation of cord blood, cord tissue and dental pulp stem cells.

For more information, please feel free to contact the foundation at:

Save the Cord Foundation
120 S. Houghton Rd., Ste. 138, PMB 271
Tucson, AZ 85748
Tel: (520) 419-0269

Click on this link to view the Save the Cord Foundation Video: http://www.savethecordfoundation.org/video_scf.php

Read the full story at http://www.prweb.com/releases/2013/4/prweb10683482.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
2. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
3. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
4. Global Cleantech Cluster Association Names New York City Startup Rentricity to Global Top 10 List
5. StemCyte Adds World Class Talent to its North America and Global Operations
6. Sequenom Named to NASDAQ Global Select Market
7. Synthetic Biology: Emerging Global Markets
8. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
9. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
10. Hemodialysis Machine Industry 2012 Global & China Market Research Report - ReportsnReports
11. MarketsandMarkets: Global Seed Treatment Market worth $3430.3 Million by 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... its latest innovations on its free and validated Electronic Data Capture (EDC) system ... the Outsourcing in Clinical Trials West Coast 2016 Conference in San Mateo, California ...
(Date:2/9/2016)... , Feb. 9, 2016  DNAtrix, a ... for cancer, announced that its lead product, ... Commission as an orphan medicinal product for ... form of glioma, strikes approximately 25,000 people ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> ...
(Date:2/9/2016)... 9, 2016 DelveInsight,s, ... report provides in depth insights on the ... the Protein-Tyrosine Phosphatase 1B (PTP1B) Inhibitors. The ... various stages of development including Discovery, Pre-clinical, ... and Preregistration. Report covers the product clinical ...
(Date:2/8/2016)... 2016 Novan, Inc. today announced that Director Robert ... Directors of Novan. In addition, Robert Keegan has been ... Carolina . --> North Carolina ... received a total of $32.8 million of net proceeds in a ... network originating throughout the Research Triangle area of North ...
Breaking Biology Technology:
(Date:2/8/2016)... Republic , February 8, 2016 ... global payment platform which presents innovation for clients, ... Authentication feature called VoiceKey. --> Worldcore ... which presents innovation for clients, comfort and unbeatable ... VoiceKey. --> Worldcore is ...
(Date:2/3/2016)... -- --> --> ... Identification System Market by Component (Hardware and Software), Search ... Government, Healthcare, and Transportation) and Geography - Global Forecast ... to be worth USD 8.49 Billion by 2020 at ... The transformation and technology evolution from the manual process ...
(Date:2/2/2016)... , Feb. 2, 2016 This BCC ... bioinformatic market by reviewing the recent advances in ... that drive the field forward. Includes forecast through ... Identify the challenges and opportunities that exist in ... software solution developers, as well as IT and ...
Breaking Biology News(10 mins):